[Advances in the study of cardiac M3 receptor as a novel target of antiarrhythmic drugs].
Yue
Peng
P
Department of Pharmacology, Bio-pharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin Medical University, Harbin 150086, China.
Lü
Yan-jie
YJ
Yang
Bao-feng
BF
D000818:Animals; D051668:Delayed Rectifier Potassium Channels / Q000502:physiology; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D017202:Myocardial Ischemia / Q000473:pathology / Q000503:physiopathology; D010862:Pilocarpine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D043587:Receptor, Muscarinic M3 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects*
D051668:Delayed Rectifier Potassium Channels; D010880:Piperidines; D043587:Receptor, Muscarinic M3; D010862:Pilocarpine; C042375:4-diphenylacetoxy-1,1-dimethylpiperidinium